|
Market Closed -
Euronext Paris
19:55:00 27/10/2026 +03
|
Pre-market 10:34:17 | |||
| 0.4530 EUR | +0.22% |
|
0.4530 | 0.00% |
| 10-06 | WINNERS & LOSERS: Celebrus warning; Kenmare gets takeover interest | AN |
| 09-30 | Novacyt S.A., H1 2026 Earnings Call, Sep 30, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Medical Devices
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 36.59M | - | - | |||
| 63.48B | |||||
| 54.55B | |||||
| 53.59B | |||||
| 44.75B | |||||
| 41.62B |
- Stock Market
- Stocks
- ALNOV Stock
- Charts Novacyt
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
